| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ligand Pharmaceuticals Inc (LGND) has 11 insiders with recent SEC Form 4 filings, including 5 buys and 8 sells. LGND is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 161.3K | $35.72M | - | |
| Dir | 44.0K | $9.74M | - | |
| Dir | 33.8K | $7.48M | - | |
| Dir | 32.8K | $7.25M | - | |
| Other | 30.8K | $6.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | Kozarich John W61 | Director | Sell | 934 | $125.00 | $116,750.00 | -2.0% | +47.6% | - | |
| Jun 23, 2025 | Reardon Andrew | CLO &Secretary | Sell | 500 | $114.08 | $57,042.15 | -1.5% | +48.5% | - | |
| Jun 10, 2025 | Reardon Andrew | CLO &Secretary | Sell | 500 | $114.54 | $57,270.70 | -1.5% | +46.2% | - | |
| May 15, 2025 | Reardon Andrew | CLO &Secretary | Sell | 1,000 | $104.00 | $104,000.00 | -2.9% | +50.8% | - | |
| May 9, 2025 | Davis Todd C77 | Chief Executive Officer | Buy | 9,510 | $105.20 | $1,000,456.37 | +2.1% | +40.0% | +111.9% | |
| May 9, 2025 | Espinoza Octavio45 | Chief Financial Officer | Buy | 1,500 | $104.06 | $156,090.00 | +2.8% | +40.0% | +111.9% | |
| Mar 4, 2025 | Espinoza Octavio45 | Chief Financial Officer | Sell | 5,000 | $115.03 | $575,148.50 | -20.9% | -11.8% | +81.3% | |
| Dec 23, 2024 | Espinoza Octavio45 | Chief Financial Officer | Sell | 2,104 | $116.37 | $244,850.48 | -9.2% | -1.9% | +73.5% | |
| Nov 27, 2024 | Lamattina John L | Director | Sale+OE | 2,406 | $123.65 | $297,501.90 | -7.5% | -3.1% | +65.8% | |
| Sep 23, 2024 | Reardon Andrew | CLO &Secretary | Sale+OE | 2,000 | $99.60 | $199,201.00 | -8.2% | +14.2% | +71.2% |